FDA finalizes rule allowing mail-order abortion pills

Brasil Notícia Notícia

FDA finalizes rule allowing mail-order abortion pills
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 latimes
  • ⏱ Reading Time:
  • 20 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 82%

The Food and Drug Administration on Tuesday finalized a rule change that allows women seeking abortion pills to get them through the mail, replacing a long-standing requirement that they pick up the medicine in person

pills to get them through the mail, replacing a long-standing requirement that they pick up the medicine in person.

Two drugmakers that make brand-name and generic versions of abortion pills requested the latest FDA label update. Agency rules require a company to file an application before modifying dispensing restrictions on drugs. More than half of U.S. abortions are now done with pills rather than surgery, according to the Guttmacher Institute, a research group that supports abortion rights.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

latimes /  🏆 11. in US

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

House investigation finds FDA, drug firm Biogen ignored internal concerns for Alzheimer's drugHouse investigation finds FDA, drug firm Biogen ignored internal concerns for Alzheimer's drugA congressional investigation into the FDA's review process for an Alzheimer's treatment found that the agency 'deviated' from its standard procedures to approve the Aduhelm drug with inconsistent data.
Consulte Mais informação »

FDA decision on experimental Alzheimer's drug expected this week | CNNFDA decision on experimental Alzheimer's drug expected this week | CNNThe US Food and Drug Administration could decide this week whether to grant accelerated approval to the experimental Alzheimer's drug lecanemab, according to Eisai and Biogen, the companies that make the drug.
Consulte Mais informação »

Controversial Alzheimer's drug, explained: What to know about Aduhelm, FDA and scathing reportControversial Alzheimer's drug, explained: What to know about Aduhelm, FDA and scathing reportThe FDA's approval process of Alzheimer’s drug Aduhelm has been deemed “rife with irregularities,” according to a congressional investigation. Here are takeaways from the report.
Consulte Mais informação »

FDA set to make decision on experimental Alzheimer's drug this weekFDA set to make decision on experimental Alzheimer's drug this weekThe Food and Drug Administration is expected to decide by Friday whether to grant accelerated approval for Eisai and Biogen's experimental Alzheimer's drug, lecanemab.
Consulte Mais informação »

Sesame joins the major food allergens list, FDA saysSesame joins the major food allergens list, FDA saysSesame has joined the list of major food allergens defined by law, according to the U.S. Food and Drug Administration.
Consulte Mais informação »

Sesame added to major food allergens list by FDASesame added to major food allergens list by FDAAs of Jan. 1, sesame has officially joined the list of major food allergens, the U.S. Food and Drug Administration said.
Consulte Mais informação »



Render Time: 2025-02-27 11:13:37